Malodorous Skin Lesions in a Diabetic Patient: Infectious Versus Neoplastic

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S113-S114
Author(s):  
Ismail Elbaz Younes ◽  
Julia Rewerska ◽  
Victoria Alagiozian-Angelova

Abstract Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma is a rare entity accounting for <1% of all cutaneous T-cell lymphomas. Almost all patients present with generalized skin lesions. This type of lymphoma has an extremely aggressive course with a median survival of 12 months. It tends to spread to other visceral sites, but lymph nodes are usually spared. We describe a case of a 59-year-old male with multiple necrotic malodours ulcers for several months. The first lesion was on his left thigh, followed by another lesion on his right chest and right eyelid. Medical history revealed newly diagnosed diabetes mellitus. The patient received antibiotics, presumptively for infectious etiology of the skin lesion, with no improvement. The right thigh lesion was excised and histomorphologic examination revealed a deep dermal proliferation of large-sized pleomorphic cells with marked pagetoid epidermotropism and skin ulceration. The adnexal skin structures were invaded by the lesion. The lesional cells were immunoreactive for CD3, CD7, CD8, and granzyme B; they were negative for CD4, CD5, CD56, and CD30. The immunophenotype confirms the entity that we have at hand in addition to the similar clinical picture that the patient presented with. This disease usually shows clonal TR gene rearrangements; nonetheless, no specific mutational aberration has been described. Our patient received chemotherapy; however, new lesions continued to erupt and he opted to proceed with palliative care. Clinical information is needed to give this diagnosis as it may look identical to a variant of lymphomatoid papulosis (type D), CD8-positive cutaneous T-cell lymphoma. We present this case due to the importance of clinical pathologic coloration to prevent misdiagnosis with mimickers as the ones pointed out earlier, and it is a provisional rare entity in the 2018 WHO classification of Tumors of Haematopoietic and Lymphoid Tissues.

2014 ◽  
Vol 94 (4) ◽  
pp. 474-475 ◽  
Author(s):  
R Andersen ◽  
M Larsen ◽  
T Poulsen ◽  
A Lauritzen ◽  
L Skov

2019 ◽  
Vol 5 (3) ◽  
pp. 264-266
Author(s):  
Emilie Doré Badje ◽  
Trilok Tejasvi ◽  
Alexandra Hristov

2010 ◽  
Vol 34 (8) ◽  
pp. 1168-1175 ◽  
Author(s):  
Andrea Saggini ◽  
Andrea Gulia ◽  
Zsolt Argenyi ◽  
Regina Fink-Puches ◽  
Amelia Lissia ◽  
...  

2020 ◽  
Vol 8 ◽  
pp. 232470962098153
Author(s):  
Caitlin Sullivan ◽  
Arya Loghmani ◽  
Katharine Thomas ◽  
Rachna Jetly-Shridhar ◽  
Rajasree Pia Chowdry

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare peripheral cytotoxic T-cell lymphoma, clinically resembling panniculitis. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of immune overactivation, triggered by underlying conditions. SPTCL presenting with HLH may represent a severe and rapidly progressive disease course. Currently, there is no standardized approach to treatment of HLH secondary to underlying SPTCL. A 34-year-old Asian male presented with a several months history of high fevers, weight loss, and nonpruritic purple discoloration of the skin. He had a skin biopsy showing atypical lymphohistiocytic panniculitis with dermal mucinosis and erythrophagocytosis consistent with SPTCL. The patient was initiated on treatment with dexamethasone and cyclosporine A. Almost immediate improvement of his skin lesions was noted and laboratory abnormalities trended toward baseline within 2 weeks. He noted complete symptom resolution after 3 months on therapy. SPTCL may be treated effectively with cyclosporine A and steroids to achieve rapid clinical and symptom management of this rare malignancy.


Sign in / Sign up

Export Citation Format

Share Document